Rac GTPases in Hematological Malignancies

被引:18
作者
Durand-Onayli, Valerie [1 ]
Haslauer, Theresa [1 ]
Haerzschel, Andrea [1 ]
Hartmann, Tanja Nicole [1 ,2 ,3 ]
机构
[1] Paracelsus Med Univ, Dept Internal Med Hematol Med Oncol Hemostaseol I, Canc Cluster Salzburg, Ctr Oncol,SCRI,LIMCR, A-5020 Salzburg, Austria
[2] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany
[3] Univ Freiburg, Med Ctr, D-79106 Freiburg, Germany
基金
奥地利科学基金会;
关键词
Rac GTPases; leukemia; lymphoma; microenvironment; cancer; migration; survival; proliferation; CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITOR; NUCLEOTIDE EXCHANGE FACTOR; HEMATOPOIETIC STEM-CELLS; RHO-GTPASES; LYMPHOBLASTIC-LEUKEMIA; PROGNOSTIC RELEVANCE; THERAPEUTIC TARGET; TYROSINE KINASE; CDC42; GTPASES;
D O I
10.3390/ijms19124041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies.
引用
收藏
页数:24
相关论文
共 139 条
[1]   Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia [J].
Aghebati-Maleki, Leili ;
Shabani, Mahdi ;
Baradaran, Behzad ;
Motallebnezhad, Morteza ;
Majidi, Jafar ;
Yousefi, Mehdi .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 :814-822
[2]   A role for Cdc42 in macrophage chemotaxis [J].
Allen, WE ;
Zicha, D ;
Ridley, AJ ;
Jones, GE .
JOURNAL OF CELL BIOLOGY, 1998, 141 (05) :1147-1157
[3]   CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling [J].
Arnaud, Marie-Pierre ;
Vallee, Audrey ;
Robert, Guillaume ;
Bonneau, Jacinthe ;
Leroy, Christine ;
Varin-Blank, Nadine ;
Rio, Anne-Gaelle ;
Troadec, Marie-Berengere ;
Galibert, Marie-Dominique ;
Gandemer, Virginie .
BLOOD, 2015, 126 (15) :1802-1812
[4]   Mimicking the microenvironment in chronic lymphocytic leukaemia where does the journey go? [J].
Asslaber, Daniela ;
Groessinger, Eva M. ;
Girbl, Tamara ;
Hofbauer, Sebastian W. ;
Egle, Alexander ;
Weiss, Lukas ;
Greil, Richard ;
Hartmann, Tanja N. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) :711-714
[5]   RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma [J].
Azab, Abdel Kareem ;
Azab, Feda ;
Blotta, Simona ;
Pitsillides, Costas M. ;
Thompson, Brian ;
Runnels, Judith M. ;
Roccaro, Aldo M. ;
Ngo, Hai T. ;
Melhem, Molly R. ;
Sacco, Antonio ;
Jia, Xiaoying ;
Anderson, Kenneth C. ;
Lin, Charles P. ;
Rollins, Barrett J. ;
Ghobrial, Irene M. .
BLOOD, 2009, 114 (03) :619-629
[6]   Targeting protein prenylation for cancer therapy [J].
Berndt, Norbert ;
Hamilton, Andrew D. ;
Sebti, Said M. .
NATURE REVIEWS CANCER, 2011, 11 (11) :775-791
[7]   A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor [J].
Bidaud-Meynard, Aurelien ;
Arma, Daniela ;
Taouji, Said ;
Laguerre, Michel ;
Dessolin, Jean ;
Rosenbaum, Jean ;
Chevet, Eric ;
Moreau, Violaine .
BIOCHEMICAL JOURNAL, 2013, 450 :55-62
[8]   Regulation of innate immunity by Rho GTPases [J].
Bokoch, GM .
TRENDS IN CELL BIOLOGY, 2005, 15 (03) :163-171
[9]   GEFs and GAPs: Critical elements in the control of small G proteins [J].
Bos, Johannes L. ;
Rehmann, Holger ;
Wittinghofer, Alfred .
CELL, 2007, 129 (05) :865-877
[10]   Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesis [J].
Bosco, Emily E. ;
Ni, Wenjun ;
Wang, Lei ;
Guo, Fukun ;
Johnson, James F. ;
Zheng, Yi .
BLOOD, 2010, 115 (16) :3320-3328